Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma.
Motzer RJ, Choueiri TK, McDermott DF, Powles T, Vano YA, Gupta S, Yao J, Han C, Ammar R, Papillon-Cavanagh S, Saggi SS, McHenry MB, Ross-Macdonald P, Wind-Rotolo M.
Motzer RJ, et al.
J Immunother Cancer. 2022 Mar;10(3):e004316. doi: 10.1136/jitc-2021-004316.
J Immunother Cancer. 2022.
PMID: 35304405
Free PMC article.